{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:07:37Z","timestamp":1780409257534,"version":"3.54.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s40618-020-01343-0","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T06:03:37Z","timestamp":1594015417000},"page":"209-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?"],"prefix":"10.1007","volume":"44","author":[{"given":"M.","family":"Parolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vettor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Steeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2807-7651","authenticated-orcid":false,"given":"P.","family":"Maffei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"issue":"3189","key":"1343_CR1","first-page":"3202","volume":"119","author":"S Melmed","year":"2009","unstructured":"Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Investig 119(3189):3202","journal-title":"J Clin Investig"},{"key":"1343_CR2","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355:2558\u20132573","journal-title":"N Engl J Med"},{"issue":"1","key":"1343_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"40","author":"MR Gadelha","year":"2019","unstructured":"Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40(1):268\u2013332. https:\/\/doi.org\/10.1210\/er.2018-00115","journal-title":"Endocr Rev"},{"issue":"1","key":"1343_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-18-0255","volume":"179","author":"F Bolfi","year":"2018","unstructured":"Bolfi F, Neves AF, Boguszewski CL, Nunes-Nogueira VS (2018) Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur J Endocrinol 179(1):59\u201371","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1343_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fendo.2019.00437","volume":"24","author":"P Maffei","year":"2019","unstructured":"Maffei P, Dassie F, Wennberg A, Parolin M, Vettor R (2019) The Endothelium in Acromegaly. Front Endocrinol (Lausanne) 24(10):437. https:\/\/doi.org\/10.3389\/fendo.2019.00437","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1343_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11102-018-0911-5","volume":"21","author":"M Parolin","year":"2018","unstructured":"Parolin M, Dassie F, Martini C, Mioni R, Russo L, Fallo F, Rossato M, Vettor R, Maffei P, Pagano C (2018) Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis. Pituitary 21(6):653\u2013662. https:\/\/doi.org\/10.1007\/s11102-018-0911-5","journal-title":"Pituitary"},{"key":"1343_CR7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11102-017-0797-7","volume":"20","author":"R Pivonello","year":"2017","unstructured":"Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, Galdiero M, Colao A (2017) Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20:46\u201362","journal-title":"Pituitary"},{"key":"1343_CR8","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.ijcard.2012.11.109","volume":"167","author":"S Mosca","year":"2013","unstructured":"Mosca S, Paolillo S, Colao A, Bossone E, Cittadini A, Iudice FL, Parente A, Conte S, Rengo G, Leosco D, Trimarco B, Filardi PP (2013) Cardiovascular involvement in patients affected by acromegaly: an appraisal. Int J Cardiol 167:1712\u20131718","journal-title":"Int J Cardiol"},{"issue":"2","key":"1343_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12020-016-1191-3","volume":"55","author":"AM Ramos-Lev\u00ed","year":"2017","unstructured":"Ramos-Lev\u00ed AM, Marazuela M (2017) Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management. Endocrine 55(2):346\u2013359","journal-title":"Endocrine"},{"issue":"1","key":"1343_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yjmcc.2009.08.021","volume":"48","author":"K Ono","year":"2010","unstructured":"Ono K, Iijima T (2010) Cardiac T-type Ca2+ channels in the heart. J Mol Cell Cardiol 48(1):65\u201370","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"1343_CR11","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1073\/pnas.87.12.4655","volume":"87","author":"XP Xu","year":"1990","unstructured":"Xu XP, Best PM (1990) Increase in T-type calcium current in atrial myocytes from adult rats with growth hormone-secreting tumors. Proc Natl Acad Sci 87(12):4655\u20134659","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"1343_CR12","doi-asserted-by":"crossref","first-page":"H935","DOI":"10.1152\/ajpheart.1991.260.3.H935","volume":"260","author":"XP Xu","year":"1991","unstructured":"Xu XP, Best PM (1991) Decreased transient outward K+ current in ventricular myocytes from acromegalic rats. Am J Physiol Heart Circ Physiol 260(3):H935\u2013H942","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"1343_CR13","doi-asserted-by":"crossref","first-page":"H2599","DOI":"10.1152\/ajpheart.1997.272.6.H2599","volume":"272","author":"WE Guo","year":"1997","unstructured":"Guo WE, Kada KE, Kamiya KA, Toyama JU (1997) IGF-I regulates K (+)-channel expression of cultured neonatal rat ventricular myocytes. Am J Physiol Heart Circ Physiol 272(6):H2599\u2013H2606","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"1343_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/01.RES.83.1.50","volume":"83","author":"A Cittadini","year":"1998","unstructured":"Cittadini A, Ishiguro Y, Str\u00a8omer H, Spindler M, Moses AC, Clark R, Douglas PS, Ingwall JS, Morgan JP (1998) Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ Res 83(1):50\u201359","journal-title":"Circ Res"},{"issue":"2","key":"1343_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.RES.79.2.227","volume":"79","author":"H Str\u00f6mer","year":"1996","unstructured":"Str\u00f6mer H, Cittadini A, Douglas PS, Morgan JP (1996) Exogenously administered growth hormone and insulin-like growth factor-I alter intracellular Ca2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart. Circ Res 79(2):227\u2013236","journal-title":"Circ Res"},{"issue":"2","key":"1343_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.RES.0000051885.70159.12","volume":"92","author":"D von Lewinski","year":"2003","unstructured":"von Lewinski D, Voss K, H\u00a8ulsmann S, K\u00a8ogler H, Pieske B (2003) Insulin-like growth factor-1 exerts Ca2+-dependent positive inotropic effects in failing human myocardium. Circ Res 92(2):169\u2013176","journal-title":"Circ Res"},{"issue":"1","key":"1343_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/bbrc.1998.9626","volume":"252","author":"ML Solem","year":"1998","unstructured":"Solem ML, Thomas AP (1998) Modulation of cardiac Ca2+ channels by IGF1. Biochem Biophys Res Commun 252(1):151\u2013155","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1343_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0008-6363(99)00058-9","volume":"43","author":"S Kinugawa","year":"1999","unstructured":"Kinugawa S, Tsutsui H, Ide T, Nakamura R, Arimura KI, Egashira K, Takeshita A (1999) Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc Res 43(1):157\u2013164","journal-title":"Cardiovasc Res"},{"issue":"3","key":"1343_CR19","doi-asserted-by":"crossref","first-page":"H823","DOI":"10.1152\/ajpheart.1998.275.3.H823","volume":"275","author":"J Ren","year":"1998","unstructured":"Ren J, Walsh MF, Hamaty M, Sowers JR, Brown RA (1998) Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+ and NO. Am J Physiol Heart Circ Physiol 275(3):H823\u2013H830","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1343_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.eurheartj.a060047","volume":"13","author":"G Kahaly","year":"1992","unstructured":"Kahaly G, Olshausen KV, Mohr-Kahaly S, Erbel R, Boor S, Beyer J, Meyer J (1992) Arrhythmia profile in acromegaly. Eur Heart J 13:51\u201356","journal-title":"Eur Heart J"},{"issue":"5","key":"1343_CR21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00024677-200403050-00004","volume":"3","author":"G Vitale","year":"2004","unstructured":"Vitale G, Pivonello R, Lombardi G, Colao A (2004) Cardiac abnormalities in acromegaly. Treat Endocrinol 3(5):309\u2013318","journal-title":"Treat Endocrinol"},{"issue":"7\u20138","key":"1343_CR22","first-page":"287","volume":"89","author":"L Matturri","year":"1998","unstructured":"Matturri L, Varesi C, Nappo A, Cuttin MS, Rossi L (1998) Sudden cardiac death in acromegaly. Anatomopathological observation of a case. Minerva Med 89(7\u20138):287\u2013291","journal-title":"Minerva Med"},{"key":"1343_CR23","first-page":"1220092559","volume":"2010","author":"F Yokota","year":"2010","unstructured":"Yokota F, Arima H, Hirano M, Uchikawa T, Inden Y, Nagatani T, Oiso Y (2010) Normalisation of plasma growth hormone levels improved cardiac dysfunction due to acromegalic cardiomyopathy with severe fibrosis. Case Rep 2010:1220092559","journal-title":"Case Rep"},{"key":"1343_CR24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1378\/chest.72.4.495","volume":"72","author":"L Rossi","year":"1977","unstructured":"Rossi L, Thiene G, Caregaro L, Giordano R, Lauro S (1977) Dysrhythmias and sudden death in acromegalic heart disease. Clinicopathol Study Chest 72:495\u2013498","journal-title":"Clinicopathol Study Chest"},{"issue":"6","key":"1343_CR25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11102-016-0749-7","volume":"19","author":"L Warszawski","year":"2016","unstructured":"Warszawski L, Kasuki L, S\u00e1 R, Dos Santos Silva CM, Volschan I, Gottlieb I, Pedrosa RC, Gadelha MR (2016) Low frequency of cardiac arrhythmias and lack of structural heart disease in medically-na\u00efve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment. Pituitary 19(6):582\u2013589","journal-title":"Pituitary"},{"key":"1343_CR26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.44.1.130","volume":"44","author":"B Lown","year":"1971","unstructured":"Lown B, Wolf M (1971) Approaches to sudden death from coronary heart disease. Circulation 44:130\u2013142","journal-title":"Circulation"},{"key":"1343_CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/hrt.62.3.185","volume":"62","author":"EA Rodrigues","year":"1989","unstructured":"Rodrigues EA, Caruana MP, Lahiri A, Nabarro JD, Jacobs HS, Raftery EB (1989) Subclinical cardiac dysfunction in acromegaly evidence for a specific disease of heart muscle. Br Heart J 62:185\u2013194","journal-title":"Br Heart J"},{"issue":"2","key":"1343_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2265.2001.01218.x","volume":"54","author":"A Colao","year":"2001","unstructured":"Colao A, Marzullo P, Di Somma C, Lombardi G (2001) Growth hormone and the heart. Clin Endocrinol 54(2):137\u2013154","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1343_CR29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endoc Rev 25(1):102\u2013152","journal-title":"Endoc Rev"},{"issue":"02","key":"1343_CR30","first-page":"223","volume":"30","author":"MA Arias","year":"2011","unstructured":"Arias MA, Pachon M, Rodriguez-Padial L (2011) Ventricular tachycardia in acromegaly [16]. Rev Port Cardiol 30(02):223\u2013226","journal-title":"Rev Port Cardiol"},{"issue":"223","key":"1343_CR31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijcard.2016.08.249","volume":"15","author":"S Viani","year":"2016","unstructured":"Viani S, Zucchelli G, Paperini L, Soldati E, Segreti L, Di Cori A, Menichetti F, Coluccia G, Andreini D, Branchitta G, Bongiorni MG (2016) Subcutaneous Implantable Defibrillator in an acromegalic pregnant woman for secondary prevention of sudden cardiac death: When (2) technologies save (2) lives. Int J Cardiol 15(223):313","journal-title":"Int J Cardiol"},{"issue":"799","key":"1343_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/pgmj.68.799.389","volume":"68","author":"TT Tan","year":"1992","unstructured":"Tan TT, Gangaram HB, Yusoff K, Khalid BA (1992) Third degree heart block in acromegaly. Postgrad Med J 68(799):389","journal-title":"Postgrad Med J"},{"issue":"1","key":"1343_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijcard.2003.11.062","volume":"97","author":"P Maffei","year":"2004","unstructured":"Maffei P, Martini C, Mioni R, DeCarlo E, Vettor R, Sicolo N (2004) Emergency pacemaker implantation in acromegaly. Int J Cardiol 97(1):161\u2013164","journal-title":"Int J Cardiol"},{"issue":"1","key":"1343_CR34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/1516-3180.2012.6410005","volume":"133","author":"Z An","year":"2015","unstructured":"An Z, He YQ, Liu GH, Ge LL, Zhang WQ (2015) Malignant ventricular tachycardia in acromegaly: a case report. Sao Paulo Med J 133(1):55\u201359","journal-title":"Sao Paulo Med J"},{"issue":"3","key":"1343_CR35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jcem-41-3-542","volume":"41","author":"PE Cryer","year":"1975","unstructured":"Cryer PE (1975) Plasma norepinephrine and epinephrine in acromegaly. J Clin Endocrinol Metab 41(3):542\u2013545","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1343_CR36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1210\/jcem-48-5-784","volume":"48","author":"GR Van Loon","year":"1979","unstructured":"Van Loon GR (1979) Abnormal plasma catecholamine responses in acromegalics. J Clin Endocrinol Metab 48(5):784\u2013789","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1343_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/acta.0.1090019","volume":"109","author":"I Rozenberg","year":"1985","unstructured":"Rozenberg I, Manchon P, Sabatier C, Hazard J, Lhoste F (1985) Effects of thyrotrophin-releasing hormone on plasma catecholamine levels in acromegalics. Acta Endocrinol 109(1):19\u201324","journal-title":"Acta Endocrinol"},{"issue":"7","key":"1343_CR38","first-page":"2458","volume":"84","author":"M Bondanelli","year":"1999","unstructured":"Bondanelli M, Ambrosio MR, Franceschetti P, Margutti A, Trasforini G, Degli Uberti EC (1999) Diurnal rhythm of plasma catecholamines in acromegaly. J Clin Endocrinol Metab 84(7):2458\u20132467","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1343_CR39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-201X.2004.01368.x","volume":"182","author":"IJ Andersson","year":"2004","unstructured":"Andersson IJ, Barlind A, Nystr\u00f6m HC, Olsson B, Sk\u00f8tt O, Mobini R, Johansson M, Bergstr\u00f6m G (2004) Reduced sympathetic responsiveness as well as plasma and tissue noradrenaline concentration in growth hormone transgenic mice. Acta Physiol Scand 182(4):369\u2013378","journal-title":"Acta Physiol Scand"},{"issue":"Suppl 1","key":"1343_CR40","first-page":"305","volume":"85","author":"E Vanoli","year":"1990","unstructured":"Vanoli E, Schwartz PJ (1990) Sympathetic\u2013parasympathetic interaction and sudden death. Basic Res Cardiol 85(Suppl 1):305\u2013321","journal-title":"Basic Res Cardiol"},{"key":"1343_CR41","first-page":"245","volume":"21","author":"MV Kamath","year":"1993","unstructured":"Kamath MV, Fallen EL (1993) Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng 21:245\u2013311","journal-title":"Crit Rev Biomed Eng"},{"key":"1343_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/hrt.71.1.3","volume":"71","author":"M Malik","year":"1994","unstructured":"Malik M, Camm AJ (1994) Heart rate variability and clinical cardiology. Br Heart J 71:3\u20136","journal-title":"Br Heart J"},{"key":"1343_CR43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11102-014-0605-6","volume":"18","author":"A Comunello","year":"2015","unstructured":"Comunello A, Dassie F, Martini C, De Carlo E, Mioni R, Battocchio M, Paoletta A, Fallo F, Vettor R, Maffei P (2015) Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues. Pituitary 18:525\u2013534","journal-title":"Pituitary"},{"key":"1343_CR44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2005-1506","volume":"91","author":"E Resmini","year":"2006","unstructured":"Resmini E, Casu M, Patrone V et al (2006) Sympathovagal imbalance in acromegalic patients. J Clin Endocrinol Metab 91:115\u2013120","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1343_CR45","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1210\/jc.2013-4288","volume":"99","author":"D Chemla","year":"2014","unstructured":"Chemla D, Attal P, Maione L, Veyer AS, Mroue G, Baud D, Chanson P (2014) Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea. J Clin Endocrinol Metab 99(8):2925\u20132931","journal-title":"J Clin Endocrinol Metab"},{"key":"1343_CR46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.sleep.2005.03.014","volume":"6","author":"C Guilleminault","year":"2005","unstructured":"Guilleminault C, Poyares D, Rosa A, Huang YS (2005) Heart rate variability, sympathetic and vagal balance and EEG arousals in upper airway resistance and mild obstructive sleep apnea syndromes. Sleep Med 6:451\u2013457","journal-title":"Sleep Med"},{"issue":"11","key":"1343_CR47","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/1440-1681.12012","volume":"39","author":"K Zhu","year":"2012","unstructured":"Zhu K, Chemla D, Roisman G, Mao W, Bazizi S, Lefevre A, Escourrou P (2012) Overnight heart rate variability in patients with obstructive sleep apnoea: a time and frequency domain study. Clin Exp Pharmacol Physiol 39(11):901\u2013908","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"1343_CR48","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0735-1097(94)90150-3","volume":"24","author":"K Imai","year":"1994","unstructured":"Imai K, Sato H, Hori M, Kusuoka H, Ozaki H, Yokoyama H, Takeda H, Inoue M, Kamada T (1994) Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol 24(6):1529\u20131535","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR49","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00421-008-0955-8","volume":"105","author":"FX Gamelin","year":"2009","unstructured":"Gamelin FX, Baquet G, Berthoin S, Thevenet D, Nourry C, Nottin S, Bosquet L (2009) Effect of high intensity intermittent training on heart rate variability in prepubescent children. Eur J Appl Physiol 105:731\u2013738. https:\/\/doi.org\/10.1007\/s00421-008-0955-8","journal-title":"Eur J Appl Physiol"},{"issue":"18","key":"1343_CR50","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199910283411804","volume":"341","author":"CR Cole","year":"1999","unstructured":"Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS (1999) Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 341(18):1351\u20131357","journal-title":"N Engl J Med"},{"key":"1343_CR51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11102-013-0482-4","volume":"17","author":"M Dural","year":"2014","unstructured":"Dural M, Kabakci G, Cinar N et al (2014) Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly. Pituitary 17:163\u2013170","journal-title":"Pituitary"},{"issue":"2","key":"1343_CR52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11102-013-0482-4","volume":"17","author":"M Dural","year":"2014","unstructured":"Dural M, Kabakc\u0131 G, \u00c7\u0131nar N, Erba\u015f T, Canpolat U, G\u00fcrses KM, \u015eahiner L (2014) Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly. Pituitary 17(2):163\u2013170","journal-title":"Pituitary"},{"issue":"2","key":"1343_CR53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijcard.2004.12.010","volume":"104","author":"P Maffei","year":"2005","unstructured":"Maffei P, Martini C, Milanesi A, Corfini A, Mioni R, de Carlo E, Menegazzo C, Scanarini M, Vettor R, Federspil G, Sicolo N (2005) Late potentials and ventricular arrhythmias in acromegaly. Int J Cardiol 104(2):197\u2013203","journal-title":"Int J Cardiol"},{"key":"1343_CR54","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0735-1097(91)90822-Q","volume":"17","author":"G Breithardt","year":"1991","unstructured":"Breithardt G, Cain ML, EL-Sherif N, Flowers NC, Hombach V, Janse M et al (1991) Standards of analysis of ventricular late potentials using high-resolution signal-averaged electrocardiography. J Am Coll Cardiol 17:999\u20131006","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR55","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/eurheartj\/14.7.941","volume":"14","author":"P Kulakowski","year":"1993","unstructured":"Kulakowski P, Counihan PJ, Camm AJ, McKenna WJ (1993) The value oftime and frequency domain, and spectral temporal mapping analysisof the signal-averaged electrocardiogram in identification of patientswith hypertrophic cardiomyopthy at increased risk of sudden death. Eur Heart J 14:941\u2013950","journal-title":"Eur Heart J"},{"issue":"Supplement I","key":"1343_CR56","first-page":"145","volume":"85","author":"MB Simson","year":"1992","unstructured":"Simson MB (1992) Noninvasive identification of patients at high risk forsudden cardiac death. Signal-averaged electrocardiography. Circulation 85(Supplement I):145\u2013151","journal-title":"Circulation"},{"issue":"2","key":"1343_CR57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2265.2001.01319.x","volume":"55","author":"BL Herrmann","year":"2001","unstructured":"Herrmann BL, Bruch C, Saller B, Ferdin S, Dagres N, Ose C, Erbel R, Mann K (2001) Occurrence of ventricular late potentials in patients with active acromegaly. Clin Endocrinol (Oxf) 55(2):201\u2013207","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1343_CR58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacc.2003.08.038","volume":"43","author":"H Bader","year":"2004","unstructured":"Bader H, Garrigue S, Lafitte S, Reuter S, Ja\u00efs P, Ha\u00efssaguerre M, Bonnet J, Clementy J, Roudaut R (2004) Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 43(2):248\u2013256","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1343_CR59","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jacc.2004.12.003","volume":"45","author":"CM Yu","year":"2005","unstructured":"Yu CM, Zhang Q, Fung JW, Chan HC, Chan YS, Yip GW, Kong SL, Lin H, Zhang Y, Sanderson JE (2005) A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol 45(5):677\u2013684","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1343_CR60","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12020-012-9859-9","volume":"44","author":"A K\u0131r\u0131\u015f","year":"2013","unstructured":"K\u0131r\u0131\u015f A, Erem C, Turan OE, Civan N, K\u0131r\u0131\u015f G, Nuho\u011flu I, Ilter A, Ers\u00f6z HO, Mm K (2013) Left ventricular synchronicity is impaired in patients with active acromegaly. Endocrine 44(1):200\u2013206. https:\/\/doi.org\/10.1007\/s12020-012-9859-9","journal-title":"Endocrine"},{"issue":"3","key":"1343_CR61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.echo.2009.12.019","volume":"23","author":"SM Park","year":"2010","unstructured":"Park SM, Kim YH, Choi JI, Pak HN, Kim YH, Shim WJ (2010) Left atrial electromechanical conduction time can predict six-month maintenance of sinus rhythm after electrical cardioversion in persistent atrial fibrillation by Doppler tissue echocardiography. J Am Soc Echocardiogr 23(3):309\u2013314","journal-title":"J Am Soc Echocardiogr"},{"issue":"8","key":"1343_CR62","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.cjca.2015.02.026","volume":"31","author":"\u00c7 Yayla","year":"2015","unstructured":"Yayla \u00c7, Canpolat U, \u015eahinarslan A, \u00d6zkan \u00c7, Altinova AE, Yayla KG, Akbo\u011fa MK, Eyiol A, Boyaci B (2015) The assessment of atrial electromechanical delay in patients with acromegaly. Can J Cardiol 31(8):1012\u20131018","journal-title":"Can J Cardiol"},{"issue":"6","key":"1343_CR63","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/hrt.63.6.342","volume":"63","author":"CP Day","year":"1990","unstructured":"Day CP, McComb JM, Campbell RW (1990) QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Heart 63(6):342\u2013344","journal-title":"Heart"},{"issue":"2","key":"1343_CR64","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12020-012-9828-3","volume":"43","author":"M Unubol","year":"2013","unstructured":"Unubol M, Eryilmaz U, Guney E, Ture M, Akgullu C (2013) QT dispersion in patients with acromegaly. Endocrine 43(2):419\u2013423","journal-title":"Endocrine"},{"issue":"3","key":"1343_CR65","first-page":"338","volume":"54","author":"AL Mohamed","year":"1999","unstructured":"Mohamed AL, Yusoff K, Muttalif AR, Khalid BA (1999) Markers of ventricular tachyarrythmias in patients with acromegaly. Med J Malaysia 54(3):338\u2013345","journal-title":"Med J Malaysia"},{"issue":"10","key":"1343_CR66","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.hrthm.2012.05.016","volume":"9","author":"R Varkevisser","year":"2012","unstructured":"Varkevisser R, Wijers SC, van der Heyden MA, Beekman JD, Meine M, Vos MA (2012) Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in vivo. Heart Rhythm 9(10):1718\u20131726","journal-title":"Heart Rhythm"},{"issue":"4","key":"1343_CR67","doi-asserted-by":"crossref","first-page":"e0125639","DOI":"10.1371\/journal.pone.0125639","volume":"10","author":"A Orosz","year":"2015","unstructured":"Orosz A, Csajb\u00f3k \u00c9, Cz\u00e9kus C, Gavall\u00e9r H, Magony S, Valkusz Z, V\u00e1rkonyi TT, Nemes A, Baczk\u00f3 I, Forster T, Wittmann T (2015) Increased short-term beat-to-beat variability of QT interval in patients with acromegaly. PLoS ONE 10(4):e0125639","journal-title":"PLoS ONE"},{"issue":"2","key":"1343_CR68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-2828(87)80560-6","volume":"19","author":"ZY Hou","year":"1987","unstructured":"Hou ZY, Lin CI, Chiu TH, Chiang BN, Cheng KK, Ho LT (1987) Somatostatin effects in isolated human atrial fibres. J Mol Cell Cardiol 19(2):177\u2013185","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"1343_CR69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1476-5381.1987.tb08960.x","volume":"90","author":"J D\u00c3ez","year":"1987","unstructured":"D\u00c3ez J, Tamargo J (1987) Effect of somatostatin on 45Ca fluxes in guinea-pig isolated atria. Br J Pharmacol 90(2):309\u2013314","journal-title":"Br J Pharmacol"},{"issue":"2 Pt 2","key":"1343_CR70","first-page":"H483","volume":"257","author":"JW Wiley","year":"1989","unstructured":"Wiley JW, Uccioli L, Owyang C, Yamada T (1989) Somatostatin stimulates acetylcholine release in the canine heart. Am J Physiol 257(2 Pt 2):H483\u2013H487","journal-title":"Am J Physiol"},{"issue":"4 Pt 2","key":"1343_CR71","first-page":"R1001","volume":"258","author":"JA Donald","year":"1990","unstructured":"Donald JA, O'Shea JE, Lillywhite HB (1990) Somatostatin and innervation of the heart of the snake Elaphe obsoleta. Am J Physiol 258(4 Pt 2):R1001\u2013R1007","journal-title":"Am J Physiol"},{"issue":"7","key":"1343_CR72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0196-9781(86)90199-3","volume":"1","author":"G Ghirlanda","year":"1986","unstructured":"Ghirlanda G, Santarelli P, Uccioli L, Sandric S, Bellocci F, Bianchini G, Cotroneo P, Greco AV (1986) Electrophysiologic effects of somatostatin in man. Peptides 1(7):265\u2013266","journal-title":"Peptides"},{"issue":"5","key":"1343_CR73","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2265.2006.02639.x","volume":"65","author":"LM Fatti","year":"2006","unstructured":"Fatti LM, Scacchi M, Lavezzi E, Giraldi FP, De Martin M, Toja P, Michailidis G, Stramba-Badiale M, Cavagnini F (2006) Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Clin endocrinol 65(5):626\u2013633","journal-title":"Clin endocrinol"},{"key":"1343_CR74","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1507\/endocrj.47.SupplMarch_S73","volume":"47","author":"K Suyama","year":"2000","unstructured":"Suyama K, Uchida K, Tanaka T, Saito J, Noguchi Y, Nakamura S, TAtsuno I, Saito Y, Saeki N (2000) Octreotide improved ventricular arrhythmia in an acromegalic patient. Endocr J 47:S73\u2013S75","journal-title":"Endocr J"},{"issue":"6","key":"1343_CR75","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1536\/jhj.44.1027","volume":"44","author":"H Tachibana","year":"2003","unstructured":"Tachibana H, Yamaguchi H, Abe S, Sato T, Inoue S, Abe S, Yamaki M, Kubota I (2003) Improvement of ventricular arrhythmia by octreotide treatment in acromegalic cardiomyopathy. Jpn Heart J 44(6):1027\u20131031","journal-title":"Jpn Heart J"},{"issue":"11","key":"1343_CR76","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF03344070","volume":"25","author":"G Lombardi","year":"2002","unstructured":"Lombardi G, Colao A, Marzullo P, Biondi B, Palmieri E, Fazio S, Multicenter Italian Study Group on Lanreotide (2002) Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study. Jour endocrinol invest 25(11):971\u2013976","journal-title":"Jour endocrinol invest"},{"issue":"5","key":"1343_CR77","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jc.2006-2547","volume":"92","author":"P Maison","year":"2007","unstructured":"Maison P, Tropeano AI, Macquin-Mavier I, Giustina A, Chanson P (2007) Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis. J Clin Endocrinol Metab 92(5):1743\u20131747","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1343_CR78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1385\/ENDO:30:1:145","volume":"30","author":"C Erem","year":"2006","unstructured":"Erem C, Ers\u00f6z H\u00d6, Ukin\u00e7 K, Avunduk AM, Hacihasanoglu A, Ko\u00e7ak M (2006) Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia. Endocrine 30(1):145\u2013149","journal-title":"Endocrine"},{"issue":"2","key":"1343_CR79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/j.1875-9114.1998.tb03872.x","volume":"18","author":"AM Herrington","year":"1998","unstructured":"Herrington AM, George KW, Moulds CC (1998) Octreotide-induced bradycardia. Pharmacotherapy 18(2):413\u2013416","journal-title":"Pharmacotherapy"},{"issue":"4","key":"1343_CR80","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","volume":"334","author":"SW Lamberts","year":"1996","unstructured":"Lamberts SW, Van der Lely AJ, de Herder WW, Hofland LJ (1996) Octreotide. N Engl J Med 334(4):246\u2013254","journal-title":"N Engl J Med"},{"key":"1343_CR81","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.endonu.2012.09.016","volume":"60","author":"MM Lima-Mart\u00ednez","year":"2013","unstructured":"Lima-Mart\u00ednez MM, L\u00f3pez-M\u00e9ndez G, Mangupli R (2013) Bradicardia sinusal inducida por octreotide en un var\u00f3n con acromegalia. Endocrinol Nutr 60:e7\u2013e9","journal-title":"Endocrinol Nutr"},{"key":"1343_CR82","unstructured":"Drugs@FDA: FDA approved drug products. Pasireotide. https:\/\/www.accessdata.fda.gov\/ Accessed May 1, 2018"},{"issue":"1","key":"1343_CR83","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jcph.213","volume":"54","author":"A Breitschaft","year":"2014","unstructured":"Breitschaft A, Hu K, Darstein C, Ligueros-Saylan M, Jordaan P, Song D, Hudson M, Shah R (2014) Effects of subcutaneous pasireotide on cardiac repolarization in healthy volunteers: a single-center, phase i, randomized. Four-Way Crossover Study J Clin Pharmacol 54(1):75\u201386. https:\/\/doi.org\/10.1002\/jcph.213","journal-title":"Four-Way Crossover Study J Clin Pharmacol"},{"issue":"6","key":"1343_CR84","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11102-013-0539-4","volume":"17","author":"J MacKenzie Feder","year":"2014","unstructured":"MacKenzie Feder J, Bourdeau I, Vallette S, Beauregard H, Ste-Marie LG, Lacroix A (2014) Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial. Pituitary 17(6):519\u2013529. https:\/\/doi.org\/10.1007\/s11102-013-0539-4","journal-title":"Pituitary"},{"issue":"6","key":"1343_CR85","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1210\/jc.2009-2272","volume":"95","author":"S Petersenn","year":"2010","unstructured":"Petersenn S, Schopohl J, Barkan A, Mohideen P, Colao A, Abs R, Buchelt A, Ho YY, Hu K, Farrall AJ, Melmed S, Biller BM (2010) Pasireotide Acromegaly Study Group. Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial. J Clin Endocrinol Metab 95(6):2781\u20132789. https:\/\/doi.org\/10.1210\/jc.2009-2272","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1343_CR86","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11102-013-0478-0","volume":"17","author":"S Petersenn","year":"2014","unstructured":"Petersenn S, Farrall AJ, De Block C, Melmed S, Schopohl J, Caron P, Cuneo R, Kleinberg D, Colao A, Ruffin M, Hermosillo Res\u00e9ndiz K, Hughes G, Hu K, Barkan A (2014) Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter. Phase II Ext Study Pituit 17(2):132\u2013140. https:\/\/doi.org\/10.1007\/s11102-013-0478-0","journal-title":"Phase II Ext Study Pituit"},{"issue":"6","key":"1343_CR87","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/EJE-18-0616","volume":"179","author":"M Buchfelder","year":"2018","unstructured":"Buchfelder M, van der Lely AJ, Biller BMK, Webb SM, Brue T, Strasburger CJ, Ghigo E, Camacho-Hubner C, Pan K, Lavenberg J, J\u00f6nsson P, Hey-Hadavi JH (2018) Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY. Eur J Endocrinol 179(6):419\u2013427. https:\/\/doi.org\/10.1530\/EJE-18-0616","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1343_CR88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/EJE-12-0596","volume":"168","author":"RS Auriemma","year":"2012","unstructured":"Auriemma RS, Pivonello R, De Martino MC, Cudemo G, Grasso LF, Galdiero M, Perone Y, Colao A (2012) Treatment with GH receptor antagonist in acromegaly: effect on cardiac arrhythmias. Eur J Endocrinol 168(1):15\u201322","journal-title":"Eur J Endocrinol"},{"key":"1343_CR89","doi-asserted-by":"crossref","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","volume":"33","author":"L Maione","year":"2019","unstructured":"Maione L, Chanson P (2019) National acromegaly registries. Best Pract Res Clin Endocrinol Metab 33:101264 (pii: S1521-690X(19)30007-7)","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"1343_CR90","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/BF03349164","volume":"26","author":"A Giustina","year":"2003","unstructured":"Giustina A, Casanueva FF, Cavagnini F, Chanson P, Clemmons D, Frohman LA, Gaillard R, Ho K, Jaquet P, Kleinberg DL, Lamberts SW, Lombardi G, Sheppard M, Strasburger CJ, Vance ML, Wass JA, Melmed S (2003) Pituitary Society and the European Neuroendocrine Association Diagnosis and treatment of acromegaly complications. J Endocrinol Invest 26(12):1242\u20131247","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1343_CR91","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","volume":"16","author":"S Melmed","year":"2013","unstructured":"Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, Strasburger CJ, Wass JA, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3):294\u2013302. https:\/\/doi.org\/10.1007\/s11102-012-0420-x","journal-title":"Pituitary"},{"issue":"Supplement 4","key":"1343_CR92","first-page":"1","volume":"17","author":"L Katznelson","year":"2011","unstructured":"Katznelson L, Atkinson J, Cook D, Ezzat S, Hamrahian A, Miller K (2011) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update. Endocr pract 17(Supplement 4):1\u201344","journal-title":"Endocr pract"},{"issue":"11","key":"1343_CR93","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1343_CR94","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.endien.2018.05.005","volume":"65","author":"I Bernabeu","year":"2018","unstructured":"Bernabeu I, Aller J, \u00c1lvarez-Escol\u00e1 C, Fajardo-Monta\u00f1ana C, G\u00e1lvez-Moreno \u00c1, Guill\u00edn-Amarelle C, Sesmilo G (2018) Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: expert consensus. Endocrinol Diabetes Nutr (English ed) 65(5):297\u2013305","journal-title":"Endocrinol Diabetes Nutr (English ed)"},{"key":"1343_CR95","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JA, Strasburger CJ, Luger A, Clemmons DR, Giustina A (2018) A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14:552\u2013561","journal-title":"Nat Rev Endocrinol"},{"key":"1343_CR96","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz096","author":"A Giustina","year":"2019","unstructured":"Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, Bolanowski M, Bonert V, Bronstein MD, Casanueva FF, Clemmons D, Colao A, Ferone D, Fleseriu M, Frara S, Gadelha MR, Ghigo E, Gurnell M, Heaney AP, Ho K, Ioachimescu A, Katznelson L, Kelestimur F, Kopchick J, Krsek M, Lamberts S, Losa M, Luger A, Maffei P, Marazuela M, Mazziotti G, Mercado M, Mortini P, Neggers S, Pereira AM, Petersenn S, Puig-Domingo M, Salvatori R, Shimon I, Strasburger C, Tsagarakis S, van der Lely AJ, Wass J, Zatelli MC, Melmed S (2019) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz096","journal-title":"J Clin Endocrinol Metab"},{"key":"1343_CR97","doi-asserted-by":"crossref","unstructured":"Cozzi R, Ambrosio MR, Attanasio R, Bozzao A, De Marinis L, De Menis E, Guastamacchia E, Lania A, Lasio G, Logoluso F, Maffei P, Poggi M, Toscano V, Zini M, Chanson P, Katznelson L (2020) Italian Association Of Clinical Endocrinologists (Ame) And Italian Aace Chapter Position Statement For Clinical Practice: Acromegaly\u2014Part 2: Therapeutic Issues. Endocr Metab Immune Disord Drug Targets","DOI":"10.2174\/1871530320666200129113328"},{"issue":"4","key":"1343_CR98","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1177\/021849230601400423","volume":"14","author":"K Takeda","year":"2006","unstructured":"Takeda K, Kobayashi J, Nakajima H, Ishibashi-Ueda H, Kitamura S (2006) Valve repair with maze procedure in acromegaly. Asian Cardiovasc Thorac Ann 14(4):e68\u201370","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"2","key":"1343_CR99","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5761\/atcs.cr.11.01700","volume":"18","author":"T Omoto","year":"2012","unstructured":"Omoto T, Tedoriya T, Oi M, Nagano N, Miyauchi T, Ishikawa N (2012) Mitral valve repair in a patient with acromegaly. Ann Thorac Cardiovasc Surg 18(2):148\u2013150","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"8","key":"1343_CR100","doi-asserted-by":"publisher","first-page":"547","DOI":"10.11909\/j.issn.1671-5411.2018.08.003","volume":"15","author":"ZH Liu","year":"2018","unstructured":"Liu ZH, Li K, Ding YS, Qiu JX, Meng SS, Momin M, Liu SC, Yi TC, Li JP (2018) Normalization of plasma growth hormone alleviated malignant ventricular tachycardia in acromegaly. J Geriatr Cardiol 15(8):547\u2013550. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2018.08.003","journal-title":"J Geriatr Cardiol"},{"key":"1343_CR101","first-page":"13","volume":"60","author":"T Kitamura","year":"2013","unstructured":"Kitamura T, Otsuki M, Yamaoka M, Saitoh Y, Shimomura I (2013) The temporary drop of serum octreotide concentration deteriorated ventricular tachycardia in an acromegalic patient. Endocr jour EJ 60:13\u20130174","journal-title":"Endocr jour EJ"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01343-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01343-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01343-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:20:40Z","timestamp":1723188040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01343-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01343-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"30 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Does not apply to this kind of paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}